Sandoz Group AG (SDZNY)
OTCMKTS
· Delayed Price · Currency is USD
40.95
+0.84 (2.11%)
Apr 24, 2025, 12:58 PM EDT
Sandoz Group AG Employees
Sandoz Group AG had 22,049 employees as of December 31, 2024. The number of employees decreased by 584 or -2.58% compared to the previous year.
Employees
22,049
Change (1Y)
-584
Growth (1Y)
-2.58%
Revenue / Employee
$470,951
Profits / Employee
n/a
Market Cap
17.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22,049 | -584 | -2.58% |
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Northwest Biotherapeutics | 25 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Longduoduo Company | 49 |
Sandoz Group AG News
- 9 days ago - Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG - GlobeNewsWire
- 10 days ago - Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug - Benzinga
- 10 days ago - [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US - GlobeNewsWire
- 10 days ago - Amgen faces antitrust lawsuit from Sandoz over Enbrel patents - Seeking Alpha
- 10 days ago - Sandoz files antitrust litigation against Amgen regarding patient access to etanercept ... - GuruFocus
- 10 days ago - Switzerland's Sandoz files antitrust lawsuit against Amgen in US - Reuters
- 10 days ago - Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US - GlobeNewsWire
- 18 days ago - Novartis After Sandoz: The Business Without Generics - Seeking Alpha